Expression of integrins in cerebral arteriovenous and cavernous malformations

Neurosurgery

Volumn 58, Issue 1, 2006, Pages 159-167

  Seker, Aşkin ^a   Yildirim, Özlem ^a   Kurtkaya, Özlem ^a   Sav, Aydin ^a   Günel, Murat ^b   Pamir, M Necmettin ^a   Kiliç, Türker ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Arteriovenous malformation; Brain; Cavernoma; Cavernous malformation; Cerebrovascular malformation; Integrin

Indexed keywords

ALPHAVBETA5 INTEGRIN; INTEGRIN; PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

ADULT; ANGIOGENESIS; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD VESSEL WALL; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN MALFORMATION; CAVERNOUS MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBENDOTHELIUM; TURKEY (REPUBLIC);

ADULT; ENDOTHELIUM, VASCULAR; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; INTEGRINS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MIDDLE AGED; RECEPTORS, VITRONECTIN; STAINING AND LABELING; TISSUE DISTRIBUTION; TUNICA MEDIA;

EID: 30144445125     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000192174.55131.09     Document Type: Article

References (70)

1. Aoshiba K, Rennard SI, Spurzem JR: Fibronectin supports bronchial epithelial cell adhesion and survival in the absence of growth factors. Am J Physiol 273:L684-L693, 1997.
2. Avraham HK, Lee TH, Koh Y, Kim TA, Jiang S, Sussman M, Samarel AM, Avraham S: Vascular endothelial growth tactor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase. J Biol Chem 278:36661-36668, 2003.
3. Baev NI, Awad IA: Endothelial cell culture from human cerebral cavernous malformations. Stroke 29:2426-2434, 1998.
4. Bahr BA, Sheppard A, Lynch G: Fibronectin binding by brain synaptosomal membranes may not involve conventional integrins. Neuroreport 2:13-16, 1991.
5. Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS, Nikas DC, Strasser JF, Villani R, Cheresh DA, Black PM: α(v)β3 and α(v)β5 integrin expression in glioma periphery. Neurosurgery 49:380-390, 2001.
6. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM: Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61:8730-8736, 2001.
7. Bello L, Zhang J, Nikas DC, Strasser JF, Villani RM, Cheresh DA, Carroll RS, Black PM: α(v)β3 and α(v)β5 integrin expression in meningiomas. Neurosurgery 47:1185-1195, 2000.
8. Brassard DL, Maxwell E, Malkowski M, Nagabhushan TL, Kumar CC, Armstrong L: Integrin α(v)β(3)-mediated activation of apoptosis. Exp Cell Res 251:33-45, 1999.
9. Brooks PC: Role of integrins in angiogenesis. Eur J Cancer 32A:2423-2429, 1996.
10. Brown EJ: Integrin-associated proteins. Curr Opin Cell Biol 14:603-607, 2002.
11. Bruick RK, McKnight SL: Building better vasculature. Genes Dev 15:2497-2502, 2001.
12. Buttery PC, ffrench-Constant C: Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 14:199-212, 1999.
13. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395, 2000.
14. Carmeliet P: Integrin indecision. Nat Med 8:14-16, 2002.
15. Carmeliet P, Collen D: Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann N Y Acad Sci 902:249-262,2000.
16. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 407:249-257, 2000.
17. Damsky CH, Ilic D: Integrin signaling: It's where the action is. Curr Opin Cell Biol 14:594-602, 2002.
18. Diaz-Gonzalez F, Forsyth J, Steiner B, Ginsberg MH: Trans-dominant inhibition of integrin function. Mol Biol Cell 7:1939-1951, 1996.
19. El Ghalbzouri A, Lamme E, Ponec M: Crucial role of tibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 310:189-199, 2002.
20. Eliceiri BP: Integrin and growth factor receptor crosstalk. Circ Res 89:1104-1110, 2001.
21. Eliceiri BP, Cheresh DA: Adhesion events in angiogenesis. Curr Opin Cell Biol 13:563-568, 2001.
22. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA: Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4:915-924, 1999.
23. Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR: Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to α(v)beta3. Circulation 108:336-341, 2003.
24. Engvall E: Laminin variants: Why, where and when? Kidney Int 43:2-6, 1993.
25. Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL: Integrins α(v)β3 and α(v)β5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res 60:712-721, 2000.
26. Farwell AP, Dubord-Tomasetti SA: Thyroid hormone regulates the extracellular organization of laminin on astrocytes. Endocrinology 140:5014-5021, 1999.
27. Felding-Habermann B, O'Toole TE Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM: Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A 98:1853-1858, 2001.
28. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct α v integrins. Science 270:1500-1502, 1995.
29. Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA: Involvement of integrins α v β 3 and alpha v β 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A 93:9764-9769, 1996.
30. Gault J, Sarin H, Awadallah N, Shenkar R, Awad IA: Pathobiology of human cerebrovascular malformations: Basic mechanisms and clinical relevance. Neurosurgery 55:1-17, 2004.
31. Giancotti FG: A structural view of integrin activation and signaling. Dev Cell 4:149-151, 2003.
32. Giancotti FG, Ruoslahti E: Integrin signaling. Science 285:1028-1032, 1999.
33. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, Nelson-Williams C, Lifton RP: KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule- associated protein. Proc Natl Acad Sci U S A 99:10677-10682, 2002.
34. Guzeloglu-Kayisli O, Amankulor NM, Voorhees J, Luleci G, Lifton RP, Gunel M: KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 54:943-949, 2004.
35. Guzeloglu-Kayisli O, Kayisli UA, Amankulor NM, Voorhees JR, Gokce O, DiLuna ML, Laurans MS, Luleci G, Gunel M: Krev1 interaction trapped-1/cerebral cavernous malformation-1 protein expression during early angiogenesis. J Neurosurg Spine 100:481-487, 2004.
36. Harrigan MR: Angiogenic factors in the central nervous system. Neurosurgery 53:639-660, 2003.
37. Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL: Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 89:111-113, 2001.
38. Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, Dressman HK, Barbaro NM, Marchuk DA, Young WL: Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54:410-423, 2004.
39. Hashimoto T, Mesa-Tejada R, Quick CM, Bollen AW, Joshi S, Pile-Spellman J, Lawton MT, Young WL: Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 49:124-131, 2001.
40. Hynes RO: Cell adhesion: Old and new questions. Trends Cell Biol 9:M33-M37, 1999.
41. Hynes RO, Bader BL Hodivala-Dilke K: Integrins in vascular development. Braz J Med Biol Res 32:501-510, 1999.
42. Jain RK, Schlenger K, Hockel M, Yuan F: Quantitative angiogenesis assays: Progress and problems. Nat Med 3:1203-1208, 1997.
43. Jester JV, Huang J, Petroll WM, Cavanagh HD: TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFβ, PDGF and integrin signaling. Exp Eye Res 75:645-657, 2002.
44. Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O'Reilly T, Buchdunger E, Black PM, Stiles CD: Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 60:5143-5150, 2000.
45. Kilic T, Bayri Y, Ozduman K, Acar M, Diren S, Kurtkaya O, Ekinci G, Bugra K, Sav A, Ozek MM, Pamir MN: Tenascin in meningioma: Expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 51:183-192, 2002.
46. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PM: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1191, 2000.
47. Konya D, Pamir, Yildirim Ö, Kurtkaya O, Kilic K, Black PM, Kilic T: Testing the angiogenic potential of cerebrovascular malformations using rat cornea model: Utility and novel assessment of changes over time. Neurosurgery 56:1339-1346, 2005.
48. Kumar CC: Integrin α v β 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets 4:123-131, 2003.
49. MacDonald TJ, Ladisch S: Antisense to integrin α v inhibits growth and induces apoptosis in medulloblastoma cells. Anticancer Res 21:3785-3791, 2001.
50. MacDonald TJ, Taga T, Shimada H, Tabrizi P, Zlokovic BV, Cheresh DA, Laug WE: Preferential susceptibility of brain tumors to the antiangiogenic effects of an α(v) integrin antagonist. Neurosurgery 48:151-157, 2001.
51. Pesheva P, Probstmeier R, Skubitz AP, McCarthy JB, Furcht LT, Schachner M: Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion-functional relatedness to tenascin-C. J Cell Sci 107:2323-2333, 1994.
52. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM: Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat Med 8:27-34, 2002.
53. Ritchie CK, Giordano A, Khalili K: Integrin involvement in glioblastoma multiforme: Possible regulation by NF-κB. J Cell Physiol 184:214-221, 2000.
54. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38:915-924,1996.
55. Ruoslahti E: Integrin signaling and matrix assembly. Tumour Biol 17:117-124, 1996.
56. Ruoslahti E: Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76:1-20, 1999.
57. Rupp PA, Little CD: Integrins in vascular development. Circ Res 89:566-572, 2001.
58. Schmid RS, Anton ES: Role of integrins in the development of the cerebral cortex. Cereb Cortex 13:219-224, 2003.
59. Seftor RE, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJ: Role of the α v β 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A 89:1557-1561, 1992.
60. Shirakawa K, Tsuda H, Heike Y, Kato K, Asada R, Inomata M, Sasaki H, Kasumi F, Yoshimoto M, Iwanaga T, Konishi F, Terada M, Wakasugi H: Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 61:445-451, 2001.
61. Singh B, Fu C, Bhattacharya J: Vascular expression of the α(v)β(3)-integrin in lung and other organs. Am J Physiol Lung Cell Mol Physiol 278:L217-L226, 2000.
62. Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM: Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 153:933-946, 2001.
63. Sobel RA, Hinojoza JR, Maeda A, Chen M: Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions. Am J Pathol 153:405-415, 1998.
64. Sobel RA, Mitchell ME: Fibronectin in multiple sclerosis lesions. Am J Pathol 135:161-168, 1989.
65. Uranishi R, Awadallah NA, Ogunshola OO, Awad IA: Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery 50:110-116, 2002.
66. Uranishi R, Baev NI, Kim JH, Awad IA: Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery 49:671-680, 2001.
67. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA: Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48:359-367, 2001.
68. Zadeh G, Guha A: Angiogenesis in nervous system disorders. Neurosurgery 53:1362-1374, 2003.
69. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA: KRIT1 association with the integrin-binding protein ICAP-1: A new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11:389-396, 2002.
70. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC: Interaction between krit1 and icap1alpha infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953-2960, 2001.